If you took 1,000 people with CDI and gave them all vanco and took 1,000 people with CDI and gave them all fida, there would be 45% less relapses in the fida group.
With me so far?
Since a certain percentage of CDI patients die, how many lives will be saved with fida?
I expect this analysis to be discussed in ID journals and even JAMA or NEJM within the next 12 months.
Fidaxomicin will save lives when used instead of vancocin. For this reason, anyone selling now is clinically insane and needs to be on tour with Charlie Sheen.
It will be malpractice in a couple years to prescrive PO vanco instead of Dificid.
Professor you advocate using vancomycin slurry which isn't approved instead of using the gold standand oral Vanco,.. and you worry about malpractice? How many unnecessary deaths have you caused?
Face it Dificid is neutered. It has been compared to Vanco with marginal results (death is about even)... at least you recognize that that is the necessary metric wheter a person benefits from the drug or not... not the recurrence, relapse mumbo jumbo that you and OPTR is trying to sell...
The trial was just against 125 mg Vanco. Imagine comparing Dificid to the 250 mg or 500 mg Vanco that is routinely used today... the death rate would be heavily in favor of Vanco... by your logic they shouldn't be using Dificid...
Face it... Dificid is sized, measured and found wanting...
Vanco slurry is oral vanco.
PO vanco means non-IV which includes both the pulvules and the generic slurry.
To date, I've never met or seen anyone assert that vanco slurry is inferior to vancocin.
It's the same exact product in fact.
The only concern I've ever heard is that a tech screws up the dosage when preparing the slurry.
Hate to burst your bubble, but the by the No votes from the statistical panelists, the superiority of recurrence is not a slam dunk for the labeling. I now view this as only a 10% chance of going on the label, due to the highly conservative nature of the FDA. This is a great gift for a savvy short...
Proinvestor works for VPHM, OPTR's competitor.
He's been running scared for a long time, posting nonsense to the board.
He was short at $12.50, still under water. The puts he bought will expire worthless!
Proinvestor, how do you come up with the thoughts you post on this board? I recognize that everyone is all over the place on predictions, but you just consistently try to push people into selling/shorting regardless of the news/facts.
Did you listen to the panel yesterday? It seems likely the FDA will put some sort of "appropriate semantics" on the label to indicate the superiority of the drug. 10%, seriously, do you just make things up as you go?